Novel porphyrazine derivatives. Potential applications in diagnosis and cancer treatment

Informations projet

N° de convention de subvention: HPMF-CT-1999-00007

Projet clôturé

Date de début 1 Octobre 1999

Date de fin 30 Septembre 2001

Financé au titre de

• Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Coût total € 0,00

Contribution de l’UE Aucune donnée

Coordonné par

IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
United Kingdom

Objectif

This proposal represents a fundamental approach to the development of novel porphyrazine derivatives and their attendant coordination complexes. The goals include target selective biochemical agents for photodynamic therapy of cancer, soft tissue imaging and as far-IR pigments.

Champ scientifique

• medical and health sciences › clinical medicine › oncology

Programme(s)

• FP5-HUMAN POTENTIAL - Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Thème(s)

• 1.4.1.-1.2. - Marie Curie Fellowships

Appel à propositions

Data not available

Régime de financement

RGI - Research grants (individual fellowships)

Coordinateur

IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

• Contribution de l’UE: Aucune donnée
• Adresse: SOUTH KENSINGTON ; SW7 2AZ LONDON ; Royaume-Uni
• Coût total: Aucune donnée

Participants (1)

Not available

Espagne

• Contribution de l’UE: Aucune donnée
• Coût total: Aucune donnée